Search - tctmd.com

Displaying 441 - 460 of 599

Sort: Relevancy | Date

Presentation Transradial 2013

Transradial Skills in Structural Heart Disease?

Presenter: Josep Rod?s-Cabau

June 28, 2013

News Industry News

Medtronic Unveils Baseline Data Of Extreme Risk Patients Enrolled In CoreValve® U.S. Pivotal Trial

June 14, 2013

Presentation TVT 2013

An Anticoagulated Patient with Severe Paravalvular Regurgitation and Ostial Left Main Disease

Presenter: Peter Pollak

June 12, 2013

News Daily News

Meta-analysis: Disease Prevalence, Number of TAVR Candidates Growing

Yael L. Maxwell

May 31, 2013

News Daily News

Meta-análisis: Aumenta la prevalencia de la enfermedad y el número de candidatos a TAVR

Yael L. Maxwell

May 31, 2013

Presentation

Aortic Stenosis in the Elderly: Disease Prevalence and Number of Candidates for TAVR

Presenter: 201433|Ruben L. J. Osnabrugge

May 30, 2013

News Daily News

Tumor Marker Predicts TAVR Outcomes

May 29, 2013

News Industry News

POSITIVE ANIMAL DATA PRESENTED AT EuroPCR SETS STAGE FOR ADVANCING NEOVASC’S TIARATM TRANSCATHETER MITRAL VALVE INTO HUMAN TRIALS

May 23, 2013

News Industry News

Medtronic CoreValve® System Gains First Approval for Transcatheter Valve-In-Valve Procedures

May 23, 2013

News Industry News

Boston Scientific Reports Lotus™ Valve System Met Primary Performance Endpoint in REPRISE II Trial

May 22, 2013

News Industry News

Positive Patient Outcomes at One Year With Edwards Sapien XT Transcatheter Valve

May 21, 2013

News Industry News

Medtronic Finds TAVI with CoreValve® System Cost Effective for Treating Patients with Severe Aortic Stenosis

May 21, 2013

News Industry News

Medtronic CoreValve ADVANCE Study Demonstrates Low Rates of Mortality and Stroke and Sustained Valve Performance

May 21, 2013

News Daily News

Surgeons, Interventionalists Collaborate on Guidelines for Management of Aortic Stenosis

Yael L. Maxwell

May 13, 2013

News Daily News

Registry Study Explores Potential for TAVR in Low-, Intermediate-Risk Patients

May 13, 2013

News Daily News

Post-TAVR Coronary Obstruction Risk Low, Linked to Unfavorable Anatomic Features

L.A. McKeown

May 13, 2013

News Daily News

Small Study Supports Transaortic TAVR as Better Option Than Transapical

Jason Kahn

April 12, 2013

News Daily News

Percutaneous Mitral Commissurotomy Shows Long-term Success, Even with Reintervention

L.A. McKeown

April 05, 2013

News Conference News ACC 2013

PARTNER: TAVR Still Safe, Effective at 3 Years, Stroke Risk Diminished

Yael L. Maxwell

March 11, 2013

News Conference News ACC 2013

PARTNER II Cohort B Demonstrates Safety, Efficacy of Lower Profile TAVR Device

L.A. McKeown

March 09, 2013

Advertisement

Transradial Skills in Structural Heart Disease?

Medtronic Unveils Baseline Data Of Extreme Risk Patients Enrolled In CoreValve® U.S. Pivotal Trial

An Anticoagulated Patient with Severe Paravalvular Regurgitation and Ostial Left Main Disease

Meta-analysis: Disease Prevalence, Number of TAVR Candidates Growing

Meta-análisis: Aumenta la prevalencia de la enfermedad y el número de candidatos a TAVR

Aortic Stenosis in the Elderly: Disease Prevalence and Number of Candidates for TAVR

Tumor Marker Predicts TAVR Outcomes

POSITIVE ANIMAL DATA PRESENTED AT EuroPCR SETS STAGE FOR ADVANCING NEOVASC’S TIARATM TRANSCATHETER MITRAL VALVE INTO HUMAN TRIALS

Medtronic CoreValve® System Gains First Approval for Transcatheter Valve-In-Valve Procedures

Boston Scientific Reports Lotus™ Valve System Met Primary Performance Endpoint in REPRISE II Trial

Positive Patient Outcomes at One Year With Edwards Sapien XT Transcatheter Valve

Medtronic Finds TAVI with CoreValve® System Cost Effective for Treating Patients with Severe Aortic Stenosis

Medtronic CoreValve ADVANCE Study Demonstrates Low Rates of Mortality and Stroke and Sustained Valve Performance

Surgeons, Interventionalists Collaborate on Guidelines for Management of Aortic Stenosis

Registry Study Explores Potential for TAVR in Low-, Intermediate-Risk Patients

Post-TAVR Coronary Obstruction Risk Low, Linked to Unfavorable Anatomic Features

Small Study Supports Transaortic TAVR as Better Option Than Transapical

Percutaneous Mitral Commissurotomy Shows Long-term Success, Even with Reintervention

PARTNER: TAVR Still Safe, Effective at 3 Years, Stroke Risk Diminished

PARTNER II Cohort B Demonstrates Safety, Efficacy of Lower Profile TAVR Device

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content